FCOMV
Foresite Capital Opportunity Management V Portfolio holdings
AUM
$33.3M
This Quarter Return
-22.14%
1 Year Return
-46.98%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$39.7M
AUM Growth
+$39.7M
(-44%)
Cap. Flow
-$4.54M
Cap. Flow
% of AUM
-11.43%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
2
Reduced
1
Closed
2
Top Buys
| 1 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$2.71M |
| 2 |
Hims & Hers Health
HIMS
|
$1.39M |
| 3 |
Compass Therapeutics
CMPX
|
$1.2M |
Top Sells
| 1 |
HLTH
Cue Health Inc. Common Stock
HLTH
|
$4.14M |
| 2 |
Cullinan Oncology
CGEM
|
$3.46M |
| 3 |
Quantum-Si Incorporated
QSI
|
$2.24M |
Sector Composition
| 1 | Healthcare | 96.5% |
| 2 | Consumer Staples | 3.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $16M | 40.44% | 5,227,307 | – | – |
|
|
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $5.31M | 13.37% | 959,275 +490,455 | +105% | +$2.71M |
|
|
3
Compass Therapeutics
CMPX
$483M
| $4.12M | 10.38% | 1,554,250 +454,250 | +41% | +$1.2M |
|
4
Disc Medicine
IRON
$2.07B
| $4.12M | 10.37% | 2,435,125 | – | – |
|
|
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $3.68M | 9.27% | 291,667 | – | – |
|
6
Adicet Bio
ACET
$59.9M
| $2.48M | 6.26% | 170,000 | – | – |
|
|
7
Quantum-Si Incorporated
QSI
$227M
| $1.47M | 3.7% | 633,626 -964,499 | -60% | -$2.24M |
|
|
8
Hims & Hers Health
HIMS
$9.57B
| $1.39M | 3.5% | +306,431 | New | +$1.39M |
|
9
Enanta Pharmaceuticals
ENTA
$180M
| $1.08M | 2.71% | 22,750 | – | – |
|
|
10
Cullinan Oncology
CGEM
$445M
| – | – | -330,836 | Closed | -$3.46M |
|
|
HLTH
11
DELISTED
Cue Health Inc. Common Stock
HLTH
| – | – | -641,483 | Closed | -$4.14M |
|